Indivior is a specialty pharmaceuticals business.
Indivior has raised $450.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in March 2026.
Indivior's investors include Oaktree Capital Management, Piper Sandler.
Indivior is headquartered in Richmond, United States.
Indivior is a specialty pharmaceuticals business.
Indivior is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Indivior — Funding & Investors." VCBacked, March 12, 2026, https://www.vcbacked.co/company/indivior. Accessed August 13, 2026.
VCBacked. (2026). Indivior — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/indivior
{{cite web |title=Indivior — Funding & Investors |url=https://www.vcbacked.co/company/indivior |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated